Stock Earnings Investing in Apimeds Pharmaceuticals US Inc (APUS) Is Getting More Attractive Apimeds Pharmaceuticals US Inc’s filing revealed that its Chairman and CMO Kim Christopher acquired Company’s shares for reported $35981.0 on